Skip to main content
SpringerLink
Log in

Die Europäischen rt-PA-Studien beim akuten Myokardinfarkt

  • Conference paper
Thrombolytische Therapie des akuten Herzinfarkts

Zusammenfassung

In der Bundesrepublik Deutschland sterben jährlich mehr als 80 000 Menschen aufgrund eines akuten Myokardinfarktes. Haupttodesursachen sind Rhythmusstörungen und Herzinsuffizienz. Mit Einführung der Intensivstationen in den Jahren von 1960–1970 konnte die Myokardinfarktsterblichkeit von etwa 30 auf 15% vermindert werden. Während Herzrhythmusstörungen besser erkannt und behandelt werden konnten, blieb die Sterblichkeit durch Herzinsuffizienz und kardiogenen Schock unverändert hoch.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Maroko PR, Kjekshus JK, Sobel BE et al. (1971) Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43:67–82

    PubMed  CAS  Google Scholar 

  2. Maroko PR, Libby P, Covell JW et al. (1972) Precordial ST segment elevation mapping: An atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol 92:223–229

    Article  Google Scholar 

  3. Schaper W, Remysen P, Xhonneux R (1969) The size of myocardial infarction after experimental coronary artery ligation. Z Kreislaufforsch 58:904–908

    PubMed  CAS  Google Scholar 

  4. Bolooki H, Kotler MD, Lottenberg L et al. (1975) Myocardial revascularization after acute infarction. Am J Cardiol 36:395–406

    Article  PubMed  CAS  Google Scholar 

  5. Ramanathan KB, Raina S, Banka VS et al. (1978) Effects of reperfusion on the regional contraction of ischemic and nonischemic myocardium following partial coronary obstruction. Circulation 57:47–52

    PubMed  CAS  Google Scholar 

  6. White FC, Rüssel PJ, Ashraf M et al. (1981) Histologic, ultrastructural, and enzymatic measurements of infarct size following coronary artery stenosis and occlusion. Am Heart J 102:686–697

    Article  PubMed  CAS  Google Scholar 

  7. Maroko PR, Braunwald E (1973) Modification of myocardial infarction size after coronary occlusion. Ann Intern Med 79:720–733

    PubMed  CAS  Google Scholar 

  8. Reimer KA, Lowe JE, Rasmussen MM et al. (1977) The wavefront phenomenon of ischemic cell death. Circulation 56:786–794

    PubMed  CAS  Google Scholar 

  9. Schaper W (1983) Natural defense mechanisms to ischemia. Eur Heart J 4:73–78

    PubMed  Google Scholar 

  10. Schaper W, Pasyk S (1976) Influence of collateral flow on the ischemic tolerance of the heart following acute and subacute coronary occlusion. Circulation 53:57–62

    Google Scholar 

  11. Helfant RH, Vokonas PS, Gorlin R (1971)Functional importance of the human coronary collateral circulation. N Engl J Med 284:1277–1281

    Article  PubMed  CAS  Google Scholar 

  12. Fulton W, Lutz W, Donald KW (1972) Natural history of unstable angina. Lancet 1:860–870

    Article  PubMed  CAS  Google Scholar 

  13. Brosius FC, Roberts WC (1981) Significance of coronary arterial thrombus in transmural acute myocardial infarction. A study of 54 necropsy patients. Circulation 63:810–816

    Article  PubMed  Google Scholar 

  14. DeWood MA, Spores J, Notske R et al. (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897–902

    Article  PubMed  CAS  Google Scholar 

  15. Rutsch W, Schartl M, Paeprer H et al. (1985) Die intrakoronare Thrombolyse. Herz Kreislaufforsch 7:342–349

    Google Scholar 

  16. Maseri A, Minno R, Chierchia S (1975) Coronary artery spasm as a cause of acute myocardial ischemia in man. Chest 68:625–633

    Article  Google Scholar 

  17. Rentrop P, de Vivie ER, Karsch KR et al. (1979) Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase in combination with transluminal recanalization. Clin Cardiol 5:354–356

    Google Scholar 

  18. Rutsch W, Schartl M, Mathey D et al. (1982) Perkutane, transluminale, koronare Rekanalisation: Methodik, Ergebnisse und Komplikationen. Z Kardiol 71:7–13

    PubMed  CAS  Google Scholar 

  19. Rutsch W, Weber HJ, Paeprer H et al. (1980) Recanalisatioii of coronary arteries in impending myocardial infarction by means of intracoronary streptokinase infusion. Circulation 62:80

    Google Scholar 

  20. Mathey DG, Kuck KH, Tilsner V et al. (1981) Nonsurgical coronary recanalization in acute transmural myocardial infarction. Circulation 63:489–497

    Article  PubMed  CAS  Google Scholar 

  21. Rutsch W, Jatzekewitz A, Schartl M et al. (1985) One-year follow-up after thrombolytic therapy in acute myocardial infarction. Eur Heart J 6:187–192

    Google Scholar 

  22. Rutsch W, Schartl M, Disselhoff W et al. (1983) Perkutane, transluminale, koronare Rekanalisation beim akuten Myokardinfarkt, Methoden, Ergebnisse und Komplikationen. In: Trübestein G, Etzel F (eds) Fibrinolytic therapy. Schattauer, Stuttgart New York, pp 497–508

    Google Scholar 

  23. Harrison DG, Ferguson DW, Collins SM et al. (1984) Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation 69:991–997

    Article  PubMed  CAS  Google Scholar 

  24. Davies MJ, Thomas AC (1985) Plaque Assuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 53:363–373

    Article  PubMed  CAS  Google Scholar 

  25. Verstraete M (1985) Intravenous administration of a thrombolytic agent is the only realistic therapeutic approach in evolving myocardial infarction. Eur Heart J 6:586–593

    PubMed  CAS  Google Scholar 

  26. Yusuf S, Collins R, Peto R et al. (1985) Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side effects from 33 randomized controlled trials. Eur Heart J 6:556–585

    PubMed  CAS  Google Scholar 

  27. Stampfer MJ, Goldhaber SZ, Yusuf S et al. (1982) Effect of intravenous streptokinase on acute myocardial infarction. Pooled results from randomized trials. N Engl J Med 307:1180–1182

    Article  PubMed  CAS  Google Scholar 

  28. Verstraete M et al. (1979) Streptokinase in acute myocardial infarction. European cooperative study group for streptokinase treatment in acute myocardial infarction. N Engl J Med 301:797–802

    Article  Google Scholar 

  29. Boucek RJ, Murphy WP (1960) Segmental perfusion of the coronary arteries with fibrinolysin in man following a myocardial infarction. Am J Cardiol 525–533

    Google Scholar 

  30. Ruegsegger P, Nydick J, Hutter RC et al. (1959) Fibrinolytic therapy of experimental coronary thrombi with alteration of the evolution of myocardial infarction. Circulation 19:7–16

    PubMed  CAS  Google Scholar 

  31. Kordenat R, Kezdi P, Powley D et al. (1972) Experimental intracoronary thrombosis and selective in situ lysis by catheter technique. Am J Cardiol 30:640–647

    Article  PubMed  CAS  Google Scholar 

  32. Chazov EL, Mareeva LS, Mazaev AV et al. (1976) Intracoronary administration of fibrinolysin in acute myocardial infarction. Terapevticheskii Arkhiv 48:8

    PubMed  CAS  Google Scholar 

  33. Kennedy JW, Ritchie JL, Davis KB et al. (1983) Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 309:1477–1482

    Article  PubMed  CAS  Google Scholar 

  34. Simoons ML, van den Brand M, de Zwaan C et al. (1985) Improved survival after early thrombolysis in acute myocardial infarction. Lancet 11:578–582

    Article  Google Scholar 

  35. Serruys PW, Simoons ML, Suryapranata H et al. (1986) Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 7:729–742

    Article  PubMed  CAS  Google Scholar 

  36. Kennedy JW, Ritchie JL, Davis KB et al. (1985) The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. N Engl J Med 312:1073–1078

    Article  PubMed  CAS  Google Scholar 

  37. Rovelli F, de Vita C, Feruglio GA et al. (1986) Gruppo italiano per lo studio della streptochinasi nell infarto miocardico (GISSI): effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1:397–401

    Google Scholar 

  38. Schröder R, Neuhaus KL, I.S.A.M. Study Group (1986) A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days. N Engl J Med 314:1465–1471

    Article  Google Scholar 

  39. Bergmann SR, Fox KAA, Ter-Pogossian MM (1983) Clotselective coronary thrombolysis with tissue-type plasminogen activator. Science 220:1181–1183

    Article  PubMed  CAS  Google Scholar 

  40. Collen D (1980) On the regulation and control of fibrinolysis. Thromb Haemost 43:77–89

    PubMed  CAS  Google Scholar 

  41. Van de Werf F, Collen D (1985) Coronary thrombolysis with tissue-type plasminogen activator: an overview. Eur Heart J 6:902–904

    PubMed  Google Scholar 

  42. Rijken DC, Collen D (1981) Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 256:29, 4–296

    Google Scholar 

  43. Verstraete M, Bleifeld W, Brower RW et al. (1985) Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction. Lancet 11:965–969

    Article  Google Scholar 

  44. Verstraete M, Bernard R, Bory M et al. (1985) Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1:842–847

    Article  PubMed  CAS  Google Scholar 

  45. Schröder R, Biamino G, von Leitner ER et al. (1983) Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation 678:536–548

    Article  Google Scholar 

  46. Meyer J, Merx W, Schmitz H et al. (1982) Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 66:905–913

    Article  PubMed  CAS  Google Scholar 

  47. Hartzler GO, Rutherford BB, McConahay DR et al. (1983) Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 106:965–968

    Article  PubMed  CAS  Google Scholar 

  48. Serruys PW, Wijns W, van den Brand M et al. (1983) Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study. Br Heart J 50:257–265

    Article  PubMed  CAS  Google Scholar 

  49. Rutsch W, Schartl M, Schmutzler H (1986) Percutaneous transluminal coronary angioplasty in acute myocardial infarction with and without prior systemic fibrinolytic therapy. In: Höfling B (ed) Current problems in PTCA. Steinkopff, Darmstadt, pp 117–121

    Google Scholar 

  50. Gold HK, Fallon JT, Yasuda T et al. (1984) Coronary thrombolysis with recombinant human tissue-type plasminogen activator. Circulation 70:700–707

    Article  PubMed  CAS  Google Scholar 

  51. Weisfeld M, Bulkley B, Sobel B et al. (1984) A controlled randomized phase I trial of recombinant human tissue-type plasminogen activator (rt-PA) in acute myocardial infarction. Circulation 70:1012–1017

    Article  Google Scholar 

  52. Kloner RA, Ganóte CE, Jennings RB (1974) The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54:1496–1508

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. W. Rutsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Schartl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Schmutzler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiology, The Royal Infirmary, EH3 9YW, Edinburgh, Scotland, UK

    David P. de Bono M.D., F.R.C.P.

  2. Department of Cardiology, University Hospital, F-37044, Tours Cedex, France

    Mireille L. Brochier M.D.

  3. Akademisch Ziekenhuis, Thoraxcentrum, Erasmus University Rotterdam, Molewaterplein, NL-3015 DG, Rotterdam, The Netherlands

    Paul G. Hugenholtz M.D.

  4. Abteilung Innere Medizin III, Medizinische Universitätsklinik, Universität Heidelberg, Bergheimerstraße 58, D-6900, Heidelberg, Deutschland

    Wolfgang Kübler

  5. Center for Thrombosis and Vascular Research Campus Gasthuisberg, Katholieke Universiteit Leuven, Herestraat 49, B-3000, Leuven, Belgium

    Marc Verstraete M.D., Ph.D., F.R.C.P.

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Rutsch, W., Schartl, M., Schmutzler, H. (1987). Die Europäischen rt-PA-Studien beim akuten Myokardinfarkt. In: de Bono, D.P., Brochier, M.L., Hugenholtz, P.G., Kübler, W., Verstraete, M. (eds) Thrombolytische Therapie des akuten Herzinfarkts. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72754-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72754-2_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-17922-1

  • Online ISBN: 978-3-642-72754-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation